Centene Reports Strong Q1 Earnings, Raises Guidance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 28 2026
0mins
Source: seekingalpha
- Earnings Beat: Centene's Q1 non-GAAP EPS of $3.37 exceeded expectations by $1.24, reflecting the company's ongoing success in managing medical costs and boosting investor confidence.
- Revenue Growth: The company reported Q1 revenue of $49.94 billion, a 7.1% year-over-year increase, surpassing market expectations by $2.39 billion, indicating strong performance in both Medicaid and Medicare segments.
- Guidance Increase: Centene raised its 2026 premium and service revenue guidance by $1.0 billion to a range of $171.0 billion to $175.0 billion, driven by optimism in Medicaid, despite consensus expectations of $188.8 billion.
- Updated Earnings Outlook: The company updated its 2026 GAAP diluted EPS guidance floor to greater than $2.37 and adjusted diluted EPS guidance floor to greater than $3.40, both exceeding the consensus of $3.02, indicating enhanced future profitability prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CNC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CNC
Wall Street analysts forecast CNC stock price to fall
15 Analyst Rating
5 Buy
8 Hold
2 Sell
Hold
Current: 57.770
Low
32.00
Averages
43.07
High
59.00
Current: 57.770
Low
32.00
Averages
43.07
High
59.00
About CNC
Centene Corporation is a healthcare company. It provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Stocks Edge Up, Led by Semiconductor Gains
- Market Recovery: The S&P 500 index rose by 0.27%, the Dow Jones Industrial Average increased by 0.09%, and the Nasdaq 100 index climbed by 0.55%, indicating a gradual recovery of some losses this week, driven by lower bond yields and strong semiconductor stock performance.
- Bond Yield Decline: The 10-year Treasury note yield fell by 2 basis points to 4.65%, as inflation expectations weakened due to a more than 2% drop in WTI crude oil prices, providing support for the bond market and potentially influencing future interest rate decisions.
- Semiconductor Sector Strength: Nvidia's stock rose by 0.6%, with the market keenly awaiting its upcoming earnings report, which is expected to show an 80% year-over-year increase in Q1 sales, providing crucial insights into the state of the AI economy and potentially impacting industry competition.
- Mortgage Applications Drop: U.S. MBA mortgage applications fell by 2.3% in the week ending May 1, with the purchase mortgage sub-index down 4.1%, reflecting that despite the average 30-year fixed mortgage rate rising to 6.56%, housing demand remains weak, which could have long-term implications for the real estate market.
See More
Semiconductor Stocks Surge, Defensive Stocks Under Pressure
- Semiconductor Stocks Shine: Companies like Intel, Micron, and Seagate have surged over 40% in 2026, significantly exceeding their 200-day moving averages, indicating a robust momentum driven by AI and data center trades that are reshaping market dynamics.
- Storage Companies Benefit: Firms such as Seagate and Western Digital are favored by investors due to rising demand for memory and data infrastructure, further solidifying their market positions and reflecting a sustained preference for tech stocks.
- Defensive Stocks Under Pressure: Defensive consumer and healthcare stocks like Zoetis and Abbott are trading significantly below their long-term trends, illustrating a shift in investor preference towards high-beta tech stocks, resulting in severe overselling of these names.
- Cautious Sentiment in Software Sector: IT services and enterprise software companies, including Accenture and ServiceNow, feature prominently on the oversold list, indicating investor caution regarding the software trade amid slowing corporate spending and potential long-term disruptions from generative AI tools.
See More
U.S. Health Insurers Report Strong Q1 Results
- Strong Q1 Performance: Major U.S. health insurers, including UnitedHealth Group and Cigna, reported first-quarter results exceeding analysts' expectations, indicating improved cost management capabilities despite industry pressures that have seen the S&P managed care index drop over 12% since July 2023.
- Stabilizing Medical Costs: Analysts noted that while medical costs have continued to rise in government-sponsored health plans, recent performances suggest that cost trends may be stabilizing, with potential for further positive earnings estimate revisions reflecting improving fundamentals in the industry.
- Upcoming Quarter Challenges: Analysts caution that the second quarter typically serves as a test for health insurers, with historical data indicating that claims may surprise in May, prompting investors to closely monitor the upcoming months for financial performance.
- Positive Market Reaction: Despite seasonal factors impacting costs, analysts maintain an optimistic view on the industry's core strength, suggesting that the improvement in medical costs may be sustainable rather than a temporary occurrence, indicating a gradual enhancement of the industry's fundamentals.
See More
David Einhorn Recommends Five Transitioning Companies
- Acadia's Recovery Potential: Einhorn highlighted Acadia Healthcare (ACHC), which has seen its stock plummet from nearly $90 to around $25, arguing that the market's reaction is excessive; if occupancy rates of new facilities rebound, EBITDA could increase by $200 million annually, potentially doubling the stock price.
- Centene's Profit Normalization: Einhorn believes Centene (CNC) will recover from rising healthcare costs and Medicaid pricing pressures, with margins expected to normalize in the coming years, projecting a stock price increase from $56 to between $85 and $102, indicating significant undervaluation.
- Fluor's Survival and Transformation: After nearly collapsing, Fluor (FLR) is positioned at the center of several infrastructure supercycles; Einhorn noted that the company has initiated a $1.4 billion buyback program, which could retire about 20% of outstanding shares, reflecting its recovery and future demand.
- Victoria's Secret Comeback: Einhorn discussed Victoria's Secret (VSCO), which is redefining its identity after cultural backlash, with new leadership aiming for a 10% operating margin, suggesting strong recovery potential as the brand stabilizes and grows under renewed management strategies.
See More
David Einhorn Bullish on Overlooked Companies
- Acadia Healthcare: Einhorn highlighted that Acadia's newer facilities are underutilized, needing occupancy rates raised to 70-80% and improved reimbursement negotiations, with a potential share price of $56, doubling the current value.
- Centene's AI Potential: He argued that Centene could significantly benefit from AI in automating claims processing, with a projected stock value between $85 and $102, indicating substantial upside from the current $56 if margins normalize.
- Fluor's Capital Spending Opportunities: Einhorn noted that Fluor is well-positioned to capitalize on a U.S. capital spending boom across various sectors, suggesting shares could reach $115 in a few years, as the market underestimates its exposure to potential super cycles.
- Versant Media's Cash Flow Advantage: He mentioned that Versant Media remains insulated from streaming competition due to its focus on news and live sports, estimating it could generate free cash flow exceeding 60% of its market cap over the next four years for share buybacks or acquisitions.
See More
Einhorn Recommends Acadia and Centene Stocks at Sohn Conference
- Investment Recommendations: At the Sohn Investment Conference in New York, Greenlight's David Einhorn pitched Acadia Healthcare (ACHC) and Centene (CNC) as long-term investment ideas, indicating confidence in the healthcare sector and potentially attracting more investor interest in these stocks.
- Stock Performance: Centene (CNC) shares rose by 5% and Acadia Healthcare (ACHC) advanced by 3.2%, reflecting a positive market reaction to Einhorn's recommendations, which may drive short-term price increases for these companies.
- New Position Established: Greenlight initiated a new medium-sized position in Versant Media (VSNT), which was recently spun off from Comcast (CMCSA) and owns channels like MS Now, CNBC, and USA Network, demonstrating optimism about its future growth potential.
- Industry Analysis: Despite ongoing cord-cutting in the legacy cable business, Greenlight believes that over 60% of Versant's programming is tied to live news and events, making it more resilient to subscriber losses, which could provide stable returns for investors.
See More
U.S. Stocks Edge Up, Led by Semiconductor Gains
- Market Recovery: The S&P 500 index rose by 0.27%, the Dow Jones Industrial Average increased by 0.09%, and the Nasdaq 100 index climbed by 0.55%, indicating a gradual recovery of some losses this week, driven by lower bond yields and strong semiconductor stock performance.
- Bond Yield Decline: The 10-year Treasury note yield fell by 2 basis points to 4.65%, as inflation expectations weakened due to a more than 2% drop in WTI crude oil prices, providing support for the bond market and potentially influencing future interest rate decisions.
- Semiconductor Sector Strength: Nvidia's stock rose by 0.6%, with the market keenly awaiting its upcoming earnings report, which is expected to show an 80% year-over-year increase in Q1 sales, providing crucial insights into the state of the AI economy and potentially impacting industry competition.
- Mortgage Applications Drop: U.S. MBA mortgage applications fell by 2.3% in the week ending May 1, with the purchase mortgage sub-index down 4.1%, reflecting that despite the average 30-year fixed mortgage rate rising to 6.56%, housing demand remains weak, which could have long-term implications for the real estate market.
See More
Semiconductor Stocks Surge, Defensive Stocks Under Pressure
- Semiconductor Stocks Shine: Companies like Intel, Micron, and Seagate have surged over 40% in 2026, significantly exceeding their 200-day moving averages, indicating a robust momentum driven by AI and data center trades that are reshaping market dynamics.
- Storage Companies Benefit: Firms such as Seagate and Western Digital are favored by investors due to rising demand for memory and data infrastructure, further solidifying their market positions and reflecting a sustained preference for tech stocks.
- Defensive Stocks Under Pressure: Defensive consumer and healthcare stocks like Zoetis and Abbott are trading significantly below their long-term trends, illustrating a shift in investor preference towards high-beta tech stocks, resulting in severe overselling of these names.
- Cautious Sentiment in Software Sector: IT services and enterprise software companies, including Accenture and ServiceNow, feature prominently on the oversold list, indicating investor caution regarding the software trade amid slowing corporate spending and potential long-term disruptions from generative AI tools.
See More
U.S. Health Insurers Report Strong Q1 Results
- Strong Q1 Performance: Major U.S. health insurers, including UnitedHealth Group and Cigna, reported first-quarter results exceeding analysts' expectations, indicating improved cost management capabilities despite industry pressures that have seen the S&P managed care index drop over 12% since July 2023.
- Stabilizing Medical Costs: Analysts noted that while medical costs have continued to rise in government-sponsored health plans, recent performances suggest that cost trends may be stabilizing, with potential for further positive earnings estimate revisions reflecting improving fundamentals in the industry.
- Upcoming Quarter Challenges: Analysts caution that the second quarter typically serves as a test for health insurers, with historical data indicating that claims may surprise in May, prompting investors to closely monitor the upcoming months for financial performance.
- Positive Market Reaction: Despite seasonal factors impacting costs, analysts maintain an optimistic view on the industry's core strength, suggesting that the improvement in medical costs may be sustainable rather than a temporary occurrence, indicating a gradual enhancement of the industry's fundamentals.
See More
David Einhorn Recommends Five Transitioning Companies
- Acadia's Recovery Potential: Einhorn highlighted Acadia Healthcare (ACHC), which has seen its stock plummet from nearly $90 to around $25, arguing that the market's reaction is excessive; if occupancy rates of new facilities rebound, EBITDA could increase by $200 million annually, potentially doubling the stock price.
- Centene's Profit Normalization: Einhorn believes Centene (CNC) will recover from rising healthcare costs and Medicaid pricing pressures, with margins expected to normalize in the coming years, projecting a stock price increase from $56 to between $85 and $102, indicating significant undervaluation.
- Fluor's Survival and Transformation: After nearly collapsing, Fluor (FLR) is positioned at the center of several infrastructure supercycles; Einhorn noted that the company has initiated a $1.4 billion buyback program, which could retire about 20% of outstanding shares, reflecting its recovery and future demand.
- Victoria's Secret Comeback: Einhorn discussed Victoria's Secret (VSCO), which is redefining its identity after cultural backlash, with new leadership aiming for a 10% operating margin, suggesting strong recovery potential as the brand stabilizes and grows under renewed management strategies.
See More
David Einhorn Bullish on Overlooked Companies
- Acadia Healthcare: Einhorn highlighted that Acadia's newer facilities are underutilized, needing occupancy rates raised to 70-80% and improved reimbursement negotiations, with a potential share price of $56, doubling the current value.
- Centene's AI Potential: He argued that Centene could significantly benefit from AI in automating claims processing, with a projected stock value between $85 and $102, indicating substantial upside from the current $56 if margins normalize.
- Fluor's Capital Spending Opportunities: Einhorn noted that Fluor is well-positioned to capitalize on a U.S. capital spending boom across various sectors, suggesting shares could reach $115 in a few years, as the market underestimates its exposure to potential super cycles.
- Versant Media's Cash Flow Advantage: He mentioned that Versant Media remains insulated from streaming competition due to its focus on news and live sports, estimating it could generate free cash flow exceeding 60% of its market cap over the next four years for share buybacks or acquisitions.
See More
Einhorn Recommends Acadia and Centene Stocks at Sohn Conference
- Investment Recommendations: At the Sohn Investment Conference in New York, Greenlight's David Einhorn pitched Acadia Healthcare (ACHC) and Centene (CNC) as long-term investment ideas, indicating confidence in the healthcare sector and potentially attracting more investor interest in these stocks.
- Stock Performance: Centene (CNC) shares rose by 5% and Acadia Healthcare (ACHC) advanced by 3.2%, reflecting a positive market reaction to Einhorn's recommendations, which may drive short-term price increases for these companies.
- New Position Established: Greenlight initiated a new medium-sized position in Versant Media (VSNT), which was recently spun off from Comcast (CMCSA) and owns channels like MS Now, CNBC, and USA Network, demonstrating optimism about its future growth potential.
- Industry Analysis: Despite ongoing cord-cutting in the legacy cable business, Greenlight believes that over 60% of Versant's programming is tied to live news and events, making it more resilient to subscriber losses, which could provide stable returns for investors.
See More
